新冠疫情期间接受生物制剂治疗的银屑病和化脓性汗腺炎患者的皮肤表现
Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic.
作者信息
Rosi Elia, Fastame Maria Thais, Di Cesare Antonella, Silvi Gianmarco, Pimpinelli Nicola, Prignano Francesca
机构信息
Department of Health Sciences, Section of Dermatology, University of Florence, 50125 Florence, Italy.
出版信息
J Clin Med. 2021 Dec 13;10(24):5841. doi: 10.3390/jcm10245841.
The Coronavirus Disease 2019 (COVID-19) pandemic, a global public health emergency, has changed dermatology practice and daily routine in just under two years. Much has been written in the literature about COVID-19-associated skin manifestations. Nevertheless, much less has been written regarding skin manifestations in patients affected by severe immune-mediated skin diseases, e.g., psoriasis and hidradenitis suppurativa, undergoing biological treatment during the COVID-19 outbreak. Thus, the aim of this article is to provide the reader with an overview of the cutaneous manifestations during the COVID-19 pandemic in this subset of patients.
2019冠状病毒病（COVID-19）大流行是一场全球突发公共卫生事件，在不到两年的时间里改变了皮肤科的诊疗实践和日常工作。关于COVID-19相关的皮肤表现，文献中已有大量报道。然而，关于在COVID-19疫情期间接受生物治疗的重度免疫介导性皮肤病（如银屑病和化脓性汗腺炎）患者的皮肤表现，相关报道则少得多。因此，本文旨在为读者概述这一特定患者群体在COVID-19大流行期间的皮肤表现。
Zotero 插件